Carlyle to Acquire a Significant Minority Stake in CureApp, a Leading Prescription Digital Therapeutics Provider in Japan

Strategic growth investment in CureApp to support the rollout of its hypertension app and advance its new development pipeline, as digital therapeutics gain traction in Japan.

Related Keywords

Japan ,Tokyo ,Japanese ,Lonna Leong ,Genta Saito ,Kazuhiro Yamada ,Kohta Satake ,Cureapp Inc ,Global Investment Solutions ,Solasto Corporation ,Sunsho Pharmaceutical Co ,Qualicaps Co ,Colin Medical Technology ,Managing Director ,Carlyle Japan ,Representative Director ,Colin Medical ,Global Private Equity ,Global Credit ,Global Investment ,Kaya Tanabe ,Alliance ,Discount ,Health Insurance ,Healthcare ,Manufacturing ,Medical Technology ,Nasdaq ,Portfolio Management ,Writer ,Literature By Country ,Medtech ,Scottish Literature ,Thomas Carlyle ,